COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 897: Articles 8961-8970  | Next

Daily Rapid Antigen Testing in a University Setting to Inform COVID-19 Isolation Duration Policy
Earnest, R., Chen, C., Chaguza, C., Grubaugh, N. D., Wilson, M. S., Yale COVID-19 Resulting and Isolation Team
10.1101/2022.03.11.22272264 — Posted: 2022-03-13
External validation of risk scores to predict in-hospital mortality in patients hospitalized due to coronavirus disease 2019.
Hassan, S., Ramspek, C. L., Ferrari, B., van Diepen, M., Rossio, R., Knevel, R., la Mura, V., Artoni, A., Martinelli, I., Bandera, A., Nobili, A., Gori, A., Blasi, F., Canetta, C., Montano, N., Rosendaal, F. R., Peyvandi, F., LUMC COVID-19 Research Group, , COVID-19 Network working group
10.1101/2022.03.11.22271912 — Posted: 2022-03-13
Surveillance of COVID-19 cases associated with dental settings using routine health data from the East of Scotland with a description of efforts to break chains of transmission from October 2020 to December 2021.
Mc Goldrick, N., O'Keefe, E.
10.1101/2022.03.11.22272263 — Posted: 2022-03-13
Association of frailty, age, and biological sex with SARS-CoV-2 mRNA vaccine-induced immunity in older adults
Shapiro, J. R., Park, H.-S., Aytenfisu, T. Y., Caputo, C., Lee, J. S., Johnston, T. S., Li, H., Hauk, P., Jacobsen, H., Li, Y., Abrams, E., Kocot, A. J., Yang, T., Huang, Y., Cramer, S. M., Betenbaugh, M. J., Debes, A. K., Morgan, R., Milstone, A. M., Karaba, A. H., Leng, S. X., Klein, S. L.
10.1101/2022.03.11.22272269 — Posted: 2022-03-13
High vaccine effectiveness against severe Covid-19 in the elderly in Finland before and after the emergence of Omicron
Baum, U., Poukka, E., Leino, T., Kilpi, T., Nohynek, H., Palmu, A. A.
10.1101/2022.03.11.22272140 — Posted: 2022-03-13
Analysis of immunization time, amplitude, and adverse events of seven different vaccines against SARS-CoV-2 across four different countries.
Romero-Ibarguengoitia, M. E., Gonzalez-Cantu, A., Pozzi, C., Levi, R., Mollura, M., Sarti, R., Sanz-Sanchez, M. A., Rivera-Salinas, D., Hernandez-Ruiz, Y. G., Armendariz-Vazquez, A. G., Del Rio-Parra, G. F., Barco-Flores, I. A., Gonzalez-Facio, R., Azzolini, E., Barbieri, R., de Azevedo Dias, A. R., Henriques-Guimaraes, M., Bastos-Borges, A., Acciardi, C., Paez-Bo, G., Teixeira, M. M., Rescigno, M.
10.1101/2022.03.11.22272153 — Posted: 2022-03-13
The Omicron SARS-CoV-2 epidemic in England during February 2022
Chadeau-Hyam, M., Tang, D., Eales, O., Bodinier, B., Wang, H., Jonnerby, J., Whitaker, M., Elliott, J., Haw, D., Walters, C. E., Atchinson, C., Diggle, P. J., Page, A. J., Ashby, D., Barclay, W., Taylor, G., Cooke, G., Ward, H., Darzi, A., Donnelly, C. A., Elliott, P.
10.1101/2022.03.10.22272177 — Posted: 2022-03-13
Milder disease trajectory among COVID-19 patients hospitalised with the SARS-CoV-2 Omicron variant compared with the Delta variant in Norway
Stalcrantz, J., Anja, K. B., Boas, H., Veneti, L., Seppala, E. M., Aasand, N., Hungnes, O., Kvale, R., Bragstad, K., Buanes, E. A., Whittaker, R. N.
10.1101/2022.03.10.22272196 — Posted: 2022-03-13
Spatial patterns of excess mortality in the first year of the COVID-19 pandemic in Germany
Wieland, T.
10.1101/2022.03.10.22272221 — Posted: 2022-03-13
EMS prehospital response to the COVID-19 pandemic in the US: A brief literature review
Ventura, C. A. I., Denton, E. E., David, J. A., Schoenfelder, B. J., Mela, L., Lumia, R. P., Rudi, R. B., Haldar, B.
10.1101/2022.03.10.22272236 — Posted: 2022-03-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).